Overview

EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
12-week, open-label study to evaluate the effectiveness and safety of donepezil hydrochloride in Hispanic patients with mild to moderate Alzheimer's Disease (AD) in the U.S.
Phase:
Phase 4
Details
Lead Sponsor:
Eisai Inc.
Collaborator:
Pfizer
Treatments:
Donepezil